Kantonsspital St.Gallen
login

publications

Cédric Panje

title  
 
Iseli T, Fischer G, Panje C, Glatzer M, Hundsberger T, Rothermundt C, Schmidt B, Sirén C, Plasswilm L, Putora P M. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
   
Panje C, Putora P M, Hundsberger T, Hottinger A F, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss Med Wkly 2019; 149:w20153.
   
Bhadhuri A, Insinga R, Guggisberg P, Panje C, Schwenkglenks M. Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland. Swiss Med Wkly 2019; 149:w20170.
   
Panje C, Zilli T, Pra A D, Arnold W, Brouwer K, Garcia Schüler H I, Gomez S, Herrera F, Khanfir K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen D, Putora P M. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice. Radiat Oncol 2019; 14:177.
   
Maas O, Forrer F, Maas M, Panje C, Blautzik J, Brühlmeier M, Engel-Bicik I, Giovanella L, Haldemann A, Kamel M E, Kneifel S, Rottenburger C, Schaefer N, Walter M A, Weidner S, Putora P M. Variations in radioiodine ablation: decision-making after total thyroidectomy. Eur J Nucl Med Mol Imaging 2019;.
   
Panje C, Höng L, Hayoz S, Baracos V E, Herrmann E, Garcia Schüler H, Meier U R, Henke G, Schacher S, Hawle H, Gérard M A, Ruhstaller T, Plasswilm L, Swiss Group for Clinical Cancer Research (SAKK) . Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy. Radiat Oncol 2019; 14:166.
   
Panje C, Dedes K J, Matter-Walstra K, Schwenkglenks M, Gautschi O, Siano M, Aebersold D M, Plasswilm L, Lupatsch J E, Swiss Group for Clinical Cancer Research (SAKK) . A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC). Radiother Oncol 2018; 129:257-263.
   
Hirschmann A, Lupatsch J E, Schwenkglenks M, Panje C, Matter-Walstra K, Espeli V, Dedes K J, Siano M, Swiss Group of Clinical Cancer Research (SAKK) . Cost-effectiveness of nivolumab in the treatment of head and neck cancer. Oral Oncol 2018; 87:104-110.
   
Jiang L, Tang Q, Panje C, Nie H, Zhao G, Shi H. Assessment of pancreatic colloid carcinoma using F-FDG PET/CT compared with MRI and enhanced CT. Oncol Lett 2018; 16:1557-1564.
   
Panje C, Glatzer M, Sirén C, Plasswilm L, Putora P M. Treatment Options in Oncology. JCO Clin Cancer Inform 2018; 2:1-10.
   
Glatzer M, Panje C, Siren C, Cihoric N, Putora P M. Decision Making Criteria in Oncology. Oncology 2018; Sep 18:1-9:.
   
Glatzer M, Panje C, Sirén C, Cihoric N, Putora P M. Decision Making Criteria in Oncology. Oncology 2018;1-9.
   
Käsmann L, Niyazi M, Blanck O, Baues C, Baumann R, Dobiasch S, Eze C, Fleischmann D, Gauer T, Giordano F A, Goy Y, Hausmann J, Henkenberens C, Kaul D, Klook L, Krug D, Mäurer M, Panje C, Rosenbrock J, Sautter L, Schmitt D, Süß C, Thieme A H, Trommer-Nestler M, Ziegler S, Ebert N, Medenwald D, Ostheimer C, Young DEGRO Trial Group . Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review. Strahlenther Onkol 2017; 194:79-90.
   
Dal Pra A, Panje C, Zilli T, Arnold W, Brouwer K, Garcia H, Glatzer M, Gomez S, Herrera F, Kaouthar K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen D R, Engeler D, Putora P M. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice. Strahlenther Onkol 2017; 194:9-16.
   
Panje C, Glatzer M, von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L, Putora P M. Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Med Res Methodol 2017; 17:123.
   
Panje C, Panje T, Putora P M, Kim S K, haile s, Aebersold D M, Plasswilm L. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience. Radiat Oncol 2015; 10:47.
   
Putora P M, Ess S, Panje C, Hundsberger T, van Leyen K, Plasswilm L, Früh M. Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC). Clin Exp Metastasis 2015; 32:143-9.
   
Panje C, Dal Pra A, Zilli T, R Zwahlen D, Papachristofilou A, Herrera F G, Matzinger O, Plasswilm L, Putora P M. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice. Strahlenther Onkol 2015; 191:778-86.
   
Putora P M, Panje C, Papachristofilou A, Pra A, Hundsberger T, Plasswilm L. Objective consensus from decision trees. Radiat Oncol 2014; 9:270.
   
Panje C, Wang D S, Willmann J K. Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives. Invest Radiol 2013; 48:755-69.
   
Wang D S, Panje C, Pysz M A, Paulmurugan R, Rosenberg J, Gambhir S S, Schneider M, Willmann J K. Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology 2012; 264:721-32.
   
Panje C, Wang D S, Pysz M A, Paulmurugan R, Ren Y, Tranquart F, Tian L, Willmann J K. Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency. Theranostics 2012; 2:1078-91.
   
Pysz M A, Foygel K, Panje C, Needles A, Tian L, Willmann J K. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. Invest Radiol 2011; 46:187-95.
   
 
page 1 of 1